
================================================================================
FEATURE EXTRACTION SUMMARY
================================================================================

Total Patients: 169,565

FEATURE GROUPS:

1. Demographics:
   - Age (continuous + 4 categories)
   - Sex (Male/Female/Unknown)
   - Region (North America/Europe/Asia/Other)
   - Reporter type (MD/Lawyer/Consumer)

2. Disease Severity:
   - Death indicator
   - Life-threatening indicator
   - Hospitalization indicator
   - Severe disease score (0-5)

3. Polypharmacy:
   - Drug count (continuous)
   - Polypharmacy categories (1-2 / 3-5 / 6+ drugs)

4. Treatment Context:
   - Cohort (HBV_MONO / HIV_HBV / AUTOIMMUNE)
   - Cohort binary indicators

5. Drug Features:
   - Drug class (5 drugs)
   - Drug risk score (from Phase 2 ROR)

6. Target Labels (ADR Categories):
   - hepatotoxicity: 2,629.0 (1.6%)
   - nephrotoxicity: 28,688.0 (16.9%)
   - bone_tooth: 30,210.0 (17.8%)
   - hematologic: 4,473.0 (2.6%)
   - neurologic: 5,100.0 (3.0%)

================================================================================